These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 9743948)
1. Defunct hematopoietic progenitor growth and heterogeneous immunological phenotypes in acquired aplastic anemia of childhood: identification of subsets with decreased hematopoietic progenitors and increased IL15 or IL10 production. Dirksen U; Asadi-Moghaddam K; Führer M; Burdach S Klin Padiatr; 1998; 210(4):167-72. PubMed ID: 9743948 [TBL] [Abstract][Full Text] [Related]
2. Special Education: Aplastic Anemia. Teramura M; Mizoguchi H Oncologist; 1996; 1(3):187-189. PubMed ID: 10387986 [TBL] [Abstract][Full Text] [Related]
3. [Experimental principles of therapy-oriented pathogenetic classification of aplastic anemia in childhood]. Burdach S; Vöhringer R; Dilloo D; Krauth K; Hanenberg H; Göbel U Klin Padiatr; 1994; 206(4):201-7. PubMed ID: 7967417 [TBL] [Abstract][Full Text] [Related]
4. Expression of interferon-gamma and tumor necrosis factor-alpha in bone marrow T cells and their levels in bone marrow plasma in patients with aplastic anemia. Dubey S; Shukla P; Nityanand S Ann Hematol; 2005 Sep; 84(9):572-7. PubMed ID: 15815907 [TBL] [Abstract][Full Text] [Related]
5. Deficiency of CD34+ c-kit+ and CD34+38- hematopoietic precursors in aplastic anemia after immunosuppressive treatment. Manz CY; Nissen C; Wodnar-Filipowicz A Am J Hematol; 1996 Aug; 52(4):264-74. PubMed ID: 8701944 [TBL] [Abstract][Full Text] [Related]
6. Effects of cyclosporine on hematopoietic and immune functions in patients with hypoplastic myelodysplasia: in vitro and in vivo studies. Selleri C; Maciejewski JP; Catalano L; Ricci P; Andretta C; Luciano L; Rotoli B Cancer; 2002 Nov; 95(9):1911-22. PubMed ID: 12404285 [TBL] [Abstract][Full Text] [Related]
7. Flow cytometric assessment of lymphocyte subsets, lymphoid progenitors, and hematopoietic stem cells in allogeneic stem cell grafts. Theilgaard-Mönch K; Raaschou-Jensen K; Palm H; Schjødt K; Heilmann C; Vindeløv L; Jacobsen N; Dickmeiss E Bone Marrow Transplant; 2001 Dec; 28(11):1073-82. PubMed ID: 11781619 [TBL] [Abstract][Full Text] [Related]
8. Circulating activated suppressor T lymphocytes in aplastic anemia. Zoumbos NC; Gascón P; Djeu JY; Trost SR; Young NS N Engl J Med; 1985 Jan; 312(5):257-65. PubMed ID: 2981406 [TBL] [Abstract][Full Text] [Related]
9. The membrane-bound isoform of stem cell factor synergizes with soluble flt3 ligand in supporting early hematopoietic cells in long-term cultures of normal and aplastic anemia bone marrow. Slanicka Krieger M; Nissen C; Manz CY; Toksoz D; Lyman SD; Wodnar-Filipowicz A Exp Hematol; 1998 May; 26(5):365-73. PubMed ID: 9590652 [TBL] [Abstract][Full Text] [Related]
10. Bone marrow and peripheral blood lymphocyte phenotype in patients with bone marrow failure. Maciejewski JP; Hibbs JR; Anderson S; Katevas P; Young NS Exp Hematol; 1994 Oct; 22(11):1102-10. PubMed ID: 7925777 [TBL] [Abstract][Full Text] [Related]
11. Physician Education: Myelodysplastic Syndrome. Yoshida Y Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004 [TBL] [Abstract][Full Text] [Related]
12. Flt3 ligand level reflects hematopoietic progenitor cell function in aplastic anemia and chemotherapy-induced bone marrow aplasia. Wodnar-Filipowicz A; Lyman SD; Gratwohl A; Tichelli A; Speck B; Nissen C Blood; 1996 Dec; 88(12):4493-9. PubMed ID: 8977241 [TBL] [Abstract][Full Text] [Related]
13. A mouse model of lymphocyte infusion-induced bone marrow failure. Bloom ML; Wolk AG; Simon-Stoos KL; Bard JS; Chen J; Young NS Exp Hematol; 2004 Dec; 32(12):1163-72. PubMed ID: 15588941 [TBL] [Abstract][Full Text] [Related]
14. [Role of Th1 cell in the pathogenesis of aplastic anemia]. He H; Shao Z; He G; Liu H; Shi J; Fu R; Zhao M; Bai J; Jia H; Sun J; Cui Z; Chu Y; Yang T; Yang C Zhonghua Xue Ye Xue Za Zhi; 2002 Nov; 23(11):574-7. PubMed ID: 12482340 [TBL] [Abstract][Full Text] [Related]
15. Abnormal immunity and stem/progenitor cells in acquired aplastic anemia. Li JP; Zheng CL; Han ZC Crit Rev Oncol Hematol; 2010 Aug; 75(2):79-93. PubMed ID: 20045349 [TBL] [Abstract][Full Text] [Related]
16. Immunologic phenotype and function in human bone marrow, blood stem cells and umbilical cord blood. Mills KC; Gross TG; Varney ML; Heimann DG; Reed EC; Kessinger A; Talmadge JE Bone Marrow Transplant; 1996 Jul; 18(1):53-61. PubMed ID: 8831996 [TBL] [Abstract][Full Text] [Related]
17. Studies of interferon as a regulator of hematopoietic cell proliferation. Raefsky EL; Platanias LC; Zoumbos NC; Young NS J Immunol; 1985 Oct; 135(4):2507-12. PubMed ID: 2411798 [TBL] [Abstract][Full Text] [Related]
18. Establishment of a CD4+ T cell clone recognizing autologous hematopoietic progenitor cells from a patient with immune-mediated aplastic anemia. Nakao S; Takamatsu H; Yachie A; Itoh T; Yamaguchi M; Ueda M; Shiobara S; Matsuda T Exp Hematol; 1995 May; 23(5):433-8. PubMed ID: 7720814 [TBL] [Abstract][Full Text] [Related]
19. Normal bone marrow hematopoietic stem cell reserves and normal stromal cell function support the use of autologous stem cell transplantation in patients with multiple sclerosis. Papadaki HA; Tsagournisakis M; Mastorodemos V; Pontikoglou C; Damianaki A; Pyrovolaki K; Stamatopoulos K; Fassas A; Plaitakis A; Eliopoulos GD Bone Marrow Transplant; 2005 Dec; 36(12):1053-63. PubMed ID: 16205726 [TBL] [Abstract][Full Text] [Related]
20. Excessive production of tumor necrosis factor-alpha by bone marrow T lymphocytes is essential in causing bone marrow failure in patients with aplastic anemia. Hara T; Ando K; Tsurumi H; Moriwaki H Eur J Haematol; 2004 Jul; 73(1):10-6. PubMed ID: 15182332 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]